Forsidebilde av showet Compounded Semaglutide — Is It Safe?

Compounded Semaglutide — Is It Safe?

Podkast av Inception Point AI

engelsk

Helse og personlig utvikling

Tidsbegrenset tilbud

2 Måneder for 19 kr

Deretter 99 kr / MånedAvslutt når som helst.

  • 20 timer lydbøker i måneden
  • Eksklusive podkaster
  • Gratis podkaster
Kom i gang

Les mer Compounded Semaglutide — Is It Safe?

Dr. Ben Synth exposes the hidden dangers of compounded semaglutide through FDA data, quality control failures, and hundreds of adverse events. Discover why the cheaper alternative to brand-name weight-loss drugs may carry serious risks—from dosing errors to contaminated ingredients—and what patients need to know now. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Alle episoder

4 Episoder

episode Compounded Semaglutide — Is It Safe? - Separate fact from fiction with Dr. Ben Synth cover

Compounded Semaglutide — Is It Safe? - Separate fact from fiction with Dr. Ben Synth

Dr. Ben Synth investigated the booming compounded semaglutide market and uncovered hundreds of adverse event reports, alarming impurity levels, and dosing errors hidden in an unregulated gray zone. This series exposes the supply chain risks, mystery ingredients, and legal loopholes behind those cheaper weight-loss injections. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 39 s
episode Compounded Semaglutide — Is It Safe? - The Shortage Loophole: A Billion-Dollar Wild West cover

Compounded Semaglutide — Is It Safe? - The Shortage Loophole: A Billion-Dollar Wild West

Ben Synth examines how the FDA's drug shortage exemption allowed compounding pharmacies to produce cheaper semaglutide alternatives during the Ozempic and Wegovy shortage, creating a billion-dollar gray market with serious safety risks, dosing errors, and regulatory gaps that left millions of patients navigating uncertain ground. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 26 min
episode Compounded Semaglutide — Is It Safe? - What's Actually in That Vial cover

Compounded Semaglutide — Is It Safe? - What's Actually in That Vial

Ben Synth examines disturbing findings from Novo Nordisk testing: some compounded semaglutide samples contained 33% impurities, including formaldehyde, trace metals, and banned substances like BPC-157. We discuss supply chain risks, unvetted foreign suppliers, non-pharmaceutical grade ingredients, sterility failures, and fraudulent labeling that distinguish compounded versions from FDA-approved Ozempic and Wegovy. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 18 min
episode Compounded Semaglutide — Is It Safe? - 605 Adverse Events and Counting cover

Compounded Semaglutide — Is It Safe? - 605 Adverse Events and Counting

Ben Synth examines the dangers of compounded semaglutide, a cheaper alternative to FDA-approved weight loss drugs like Ozempic and Wegovy. The episode covers over 600 adverse events reported to the FDA, including severe overdoses, hospitalizations, and life-threatening complications. Through detailed analysis of regulatory data and clinical reports, Ben explores dosing errors, quality control failures, and the risks patients face. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. april 2026 - 20 min
Registrer deg for å lytte
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Enkelt å finne frem nye favoritter og lett å navigere seg gjennom innholdet i appen
Liker at det er både Podcaster (godt utvalg) og lydbøker i samme app, pluss at man kan holde Podcaster og lydbøker atskilt i biblioteket.
Bra app. Oversiktlig og ryddig. MYE bra innhold⭐️⭐️⭐️

Velg abonnementet ditt

Mest populær

Tidsbegrenset tilbud

Premium

20 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

2 Måneder for 19 kr
Deretter 99 kr / Måned

Kom i gang

Premium Plus

100 timer lydbøker

  • Eksklusive podkaster

  • Ingen annonser i Podimo shows

  • Avslutt når som helst

Prøv gratis i 14 dager
Deretter 169 kr / måned

Prøv gratis

Bare på Podimo

Populære lydbøker

Ofte stilte spørsmål

Flere spørsmål og svar
Kom i gang

2 Måneder for 19 kr. Deretter 99 kr / Måned. Avslutt når som helst.